Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

       
Total article views   HTML views PDF downloads Totals
11,575 Dovepress* 9,917+ 1,949 11,866
PubMed Central* 1,658 681 2,339
Totals 11,575 2,630 14,205
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar